NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 74 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $155,000 | -27.2% | 163,942 | +2.2% | 0.00% | -100.0% |
| Q4 2015 | $213,000 | -36.8% | 160,482 | +8.5% | 0.00% | 0.0% |
| Q3 2015 | $337,000 | +47.8% | 147,957 | +4.3% | 0.00% | 0.0% |
| Q2 2015 | $228,000 | -5.0% | 141,801 | -6.3% | 0.00% | 0.0% |
| Q1 2015 | $240,000 | 0.0% | 151,256 | +19.2% | 0.00% | 0.0% |
| Q4 2014 | $240,000 | +50.9% | 126,856 | +5.6% | 0.00% | – |
| Q3 2014 | $159,000 | -10.7% | 120,081 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $178,000 | -9.2% | 120,081 | +13.3% | 0.00% | 0.0% |
| Q1 2014 | $196,000 | -15.2% | 106,031 | -5.0% | 0.00% | 0.0% |
| Q4 2013 | $231,000 | -23.5% | 111,621 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $302,000 | -1.3% | 114,021 | -0.6% | 0.00% | 0.0% |
| Q2 2013 | $306,000 | – | 114,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sowell Financial Services LLC | 1,507,457 | $593,000 | 0.17% |
| Harel Insurance Investments & Financial Services Ltd. | 780,000 | $398,000 | 0.03% |
| Spark Investment Management LLC | 353,400 | $180,000 | 0.01% |
| LifePlan Financial Group, Inc | 28,810 | $15,000 | 0.01% |
| Greenwich Wealth Management LLC | 60,066 | $31,000 | 0.01% |
| SHINE INVESTMENT ADVISORY SERVICES INC | 19,608 | $10,000 | 0.01% |
| Virtu KCG Holdings LLC | 336,414 | $172,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $9,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $331,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377,875 | $193,000 | 0.00% |